Skip to content
← Back to this collection

PUBLICATIONS · 19965667

Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2010 Mar 11
First author
Saussele S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2010 Mar 11;115(10):1860-1. doi: 10.1182/blood-2009-12-255844.
    note
    Source null
    related pmid
    20223928
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2010 Jun;7(6):298. doi: 10.1038/nrclinonc.2010.77.
    note
    Source null
    related pmid
    20527682
    relationship
    Comment in

Authors and identifiers

  1. name
    Saussele S
    type
    Author
  2. name
    Lauseker M
    type
    Author
  3. name
    Gratwohl A
    type
    Author
  4. name
    Beelen DW
    type
    Author
  5. name
    Bunjes D
    type
    Author
  6. name
    Schwerdtfeger R
    type
    Author
  7. name
    Kolb HJ
    type
    Author
  8. name
    Ho AD
    type
    Author
  9. name
    Falge C
    type
    Author
  10. name
    Holler E
    type
    Author
  11. name
    Schlimok G
    type
    Author
  12. name
    Zander AR
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Saussele S
    type
    Author
  2. name
    Lauseker M
    type
    Author
  3. name
    Gratwohl A
    type
    Author
  4. name
    Beelen DW
    type
    Author
  5. name
    Bunjes D
    type
    Author
  6. name
    Schwerdtfeger R
    type
    Author
  7. name
    Kolb HJ
    type
    Author
  8. name
    Ho AD
    type
    Author
  9. name
    Falge C
    type
    Author
  10. name
    Holler E
    type
    Author
  11. name
    Schlimok G
    type
    Author
  12. name
    Zander AR
    type
    Author
bibliography ids
  1. nci-bib-cf5ce8aa0251817725eac03b
book metadata
content sha256
9cfdfcb581cbcfa5289eabcf523e15ca29fcfac61964312671a89c37da0b2631
document type
citation
dois
  1. 10.1182/blood-2009-08-237115
electronic publication date
display
2009 Nov 18
precision
day
year
2009
evidence scope
bibliographic_metadata_only
id
pubmed:19965667
immutable id
pubmed:19965667@9cfdfcb581cbcfa5289eabcf523e15ca29fcfac61964312671a89c37da0b2631
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
10
name
Blood
nlm unique id
7603509
pages
1880-5
volume
115
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2010 Mar 11;115(10):1860-1. doi: 10.1182/blood-2009-12-255844.
    note
    Source null
    related pmid
    20223928
    relationship
    Comment in
  2. citation
    Nat Rev Clin Oncol. 2010 Jun;7(6):298. doi: 10.1038/nrclinonc.2010.77.
    note
    Source null
    related pmid
    20527682
    relationship
    Comment in
outcomes validated
false
pmid
19965667
provenance
batch id
708c7929ee1eff455330
provider
NCBI PubMed ESummary
record sha256
e61908aadce4e051a21c6a00a536bbcdda81518fc013c9a4d1a31cbb47a1f32c
response sha256
d245af3dbc636ffc79325b3798c7bfda16faf0a3d796681b12b8d89bd68eb450
retrieved at
2026-09-09T23:46:31.496840+00:00
publication date
display
2010 Mar 11
precision
day
year
2010
publication types
  1. Clinical Trial, Phase IV
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/19965667/
title
Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV.

Preserved source evidence · Not medical advice